2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Chitosan Oligosaccharides Alleviate H 2O 2-stimulated Granulosa Cell Damage via HIF-1 α Signaling Pathway

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Oocyte maturation disorder and decreased quality are the main causes of infertility in women, and granulosa cells (GCs) provide the only microenvironment for oocyte maturation through autocrine and paracrine signaling by steroid hormones and growth factors. However, chronic inflammation and oxidative stress caused by ovarian hypoxia are the largest contributors to ovarian aging and GC dysfunction. Therefore, the amelioration of chronic inflammation and oxidative stress is expected to be a pivotal method to improve GC function and oocyte quality. In this study, we detected the protective effect of chitosan oligosaccharides (COS), on hydrogen peroxide- (H 2O 2-) stimulated oxidative damage in a human ovarian granulosa cell line (KGN). COS significantly increased cell viability, mitochondrial function, and the cellular glutathione (GSH) content and reduced apoptosis, reactive oxygen species (ROS) content, and the levels of 8-hydroxy-2′-deoxyguanosine (8-OHdG), 4-hydroxynonenal (4-HNE), hypoxia-inducible factor-1 α (HIF-1 α), and vascular endothelial-derived growth factor (VEGF) in H 2O 2-stimulated KGN cells. COS treatment significantly increased levels of the TGF- β1 and IL-10 proteins and decreased levels of the IL-6 protein. Compared with H 2O 2-stimulated KGN cells, COS significantly increased the levels of E 2 and P 4 and decreased SA- β-gal protein expression. Furthermore, COS caused significant inactivation of the HIF-1 α-VEGF pathway in H 2O 2-stimulated KGN cells. Moreover, inhibition of this pathway enhanced the inhibitory effects of COS on H 2O 2-stimulated oxidative injury and apoptosis in GCs. Thus, COS protected GCs from H 2O 2-stimulated oxidative damage and apoptosis by inactivating the HIF-1 α-VEGF signaling pathway. In the future, COS might represent a therapeutic approach for ameliorating disrupted follicle development.

          Related collections

          Most cited references83

          • Record: found
          • Abstract: found
          • Article: not found

          HIF transcription factors, inflammation, and immunity.

          The hypoxic response in cells and tissues is mediated by the family of hypoxia-inducible factor (HIF) transcription factors; these play an integral role in the metabolic changes that drive cellular adaptation to low oxygen availability. HIF expression and stabilization in immune cells can be triggered by hypoxia, but also by other factors associated with pathological stress: e.g., inflammation, infectious microorganisms, and cancer. HIF induces a number of aspects of host immune function, from boosting phagocyte microbicidal capacity to driving T cell differentiation and cytotoxic activity. Cellular metabolism is emerging as a key regulator of immunity, and it constitutes another layer of fine-tuned immune control by HIF that can dictate myeloid cell and lymphocyte development, fate, and function. Here we discuss how oxygen sensing in the immune microenvironment shapes immunological response and examine how HIF and the hypoxia pathway control innate and adaptive immunity.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019

            Liver fibrosis is an advanced liver disease condition, which could progress to cirrhosis and hepatocellular carcinoma. To date, there is no direct approved antifibrotic therapy, and current treatment is mainly the removal of the causative factor. Transforming growth factor (TGF)-β is a master profibrogenic cytokine and a promising target to treat fibrosis. However, TGF-β has broad biological functions and its inhibition induces non-desirable side effects, which override therapeutic benefits. Therefore, understanding the pleiotropic effects of TGF-β and its upstream and downstream regulatory mechanisms will help to design better TGF-β based therapeutics. Here, we summarize recent discoveries and milestones on the TGF-β signaling pathway related to liver fibrosis and hepatic stellate cell (HSC) activation, emphasizing research of the last five years. This comprises impact of TGF-β on liver fibrogenesis related biological processes, such as senescence, metabolism, reactive oxygen species generation, epigenetics, circadian rhythm, epithelial mesenchymal transition, and endothelial-mesenchymal transition. We also describe the influence of the microenvironment on the response of HSC to TGF-β. Finally, we discuss new approaches to target the TGF-β pathway, name current clinical trials, and explain promises and drawbacks that deserve to be adequately addressed.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.

              Hypoxia is a feature of the microenvironment of a growing tumor. The transcription factor NFkappaB is activated in hypoxia, an event that has significant implications for tumor progression. Here, we demonstrate that hypoxia activates NFkappaB through a pathway involving activation of IkappaB kinase-beta (IKKbeta) leading to phosphorylation-dependent degradation of IkappaBalpha and liberation of NFkappaB. Furthermore, through increasing the pool and/or activation potential of IKKbeta, hypoxia amplifies cellular sensitivity to stimulation with TNFalpha. Within its activation loop, IKKbeta contains an evolutionarily conserved LxxLAP consensus motif for hydroxylation by prolyl hydroxylases (PHDs). Mimicking hypoxia by treatment of cells with siRNA against PHD-1 or PHD-2 or the pan-prolyl hydroxylase inhibitor DMOG results in NFkappaB activation. Conversely, overexpression of PHD-1 decreases cytokine-stimulated NFkappaB reporter activity, further suggesting a repressive role for PHD-1 in controlling the activity of NFkappaB. Hypoxia increases both the expression and activity of IKKbeta, and site-directed mutagenesis of the proline residue (P191A) of the putative IKKbeta hydroxylation site results in a loss of hypoxic inducibility. Thus, we hypothesize that hypoxia releases repression of NFkappaB activity through decreased PHD-dependent hydroxylation of IKKbeta, an event that may contribute to tumor development and progression through amplification of tumorigenic signaling pathways.
                Bookmark

                Author and article information

                Contributors
                Journal
                Oxid Med Cell Longev
                Oxid Med Cell Longev
                OMCL
                Oxidative Medicine and Cellular Longevity
                Hindawi
                1942-0900
                1942-0994
                2022
                1 April 2022
                : 2022
                : 4247042
                Affiliations
                1Jiangxi Medical College, Nanchang University, Nanchang 330006, China
                2Jiangxi Provincial Key Laboratory of Reproductive Physiology and Pathology, Nanchang 330031, China
                3Health Science Center, Shenzhen University, Shenzhen 518000, China
                4Medical College, Shantou University, Shantou 515041, China
                5Reproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, Nanchang 330006, China
                6Department of Reproductive Health, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen 518033, China
                Author notes

                Academic Editor: J. L Franco

                Author information
                https://orcid.org/0000-0001-9080-7534
                https://orcid.org/0000-0003-2944-9680
                https://orcid.org/0000-0002-2345-7893
                Article
                10.1155/2022/4247042
                8993563
                35401926
                8722e52e-a249-4b2f-a9f3-90ab8f7c0bde
                Copyright © 2022 Ziwei Yang et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 19 November 2021
                : 2 January 2022
                : 2 March 2022
                Funding
                Funded by: National Natural Science Foundation of China
                Award ID: 31460307
                Award ID: 81671455
                Funded by: Basic Research Scheme of Shenzhen Science and Technology Innovation Commission
                Funded by: Natural Scientific Foundation of Jiangxi Province
                Award ID: 20192BAB215009
                Categories
                Research Article

                Molecular medicine
                Molecular medicine

                Comments

                Comment on this article